Anteris Technologies Global (NASDAQ:AVR) versus Establishment Labs (NASDAQ:ESTA) Head-To-Head Comparison

Anteris Technologies Global (NASDAQ:AVR) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Earnings & Valuation

This table compares Anteris Technologies Global and Establishment Labs”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$2.71 million	58.79	N/A	N/A	N/A
Establishment Labs	$166.03 million	6.05	-$78.50 million	($2.98)	-11.68

Anteris Technologies Global has higher earnings, but lower revenue than Establishment Labs.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Anteris Technologies Global and Establishment Labs, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	0	0	4	0	3.00
Establishment Labs	0	2	4	0	2.67

Anteris Technologies Global currently has a consensus price target of $16.50, indicating a potential upside of 273.30%. Establishment Labs has a consensus price target of $57.40, indicating a potential upside of 64.90%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Anteris Technologies Global is more favorable than Establishment Labs.

Profitability

This table compares Anteris Technologies Global and Establishment Labs’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	N/A	N/A	N/A
Establishment Labs	-46.13%	-184.55%	-24.81%

Institutional & Insider Ownership

72.9% of Establishment Labs shares are held by institutional investors. 11.1% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Anteris Technologies Global beats Establishment Labs on 6 of the 9 factors compared between the two stocks.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.